Related references
Note: Only part of the references are listed.Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study- results at 5 years of follow-up
Maria A. Martin-Martinez et al.
RHEUMATOLOGY (2021)
Improved Incidence of Cardiovascular Disease in Patients With Incident Rheumatoid Arthritis in the 2000s: A Population-based Cohort Study
Elena Myasoedova et al.
JOURNAL OF RHEUMATOLOGY (2021)
Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study
Ivan Ferraz-Amaro et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
Ivan Ferraz-Amaro et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents
Federico Carbone et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study
Elena Nikiphorou et al.
HEART (2020)
Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study
Alfonso Corrales et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Epidemiology of gout in Hong Kong: a population-based study from 2006 to 2016
Man Fung Tsoi et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Brendan M. Everett et al.
CIRCULATION (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: A cross-sectional study based on hospital medical records in 10 years
Kun Zou et al.
PLOS ONE (2017)
Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities
Aikaterini Arida et al.
RHEUMATOLOGY (2017)
Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study
Elke E. A. Arts et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis
Audrey S. L. Low et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Camille Roubille et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis
Anne M. Kerola et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Defining remission in rheumatoid arthritis
David Felson
ANNALS OF THE RHEUMATIC DISEASES (2012)
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
Juan Antonio Avina-Zubieta et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
Kaisa M. Maeki-Petaejae et al.
CIRCULATION (2012)
Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity
Jonathan L. Marks et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2012)
Systematic Review and Meta-Analysis: Anti-Tumor Necrosis Factor α Therapy and Cardiovascular Events in Rheumatoid Arthritis
Cheryl Barnabe et al.
ARTHRITIS CARE & RESEARCH (2011)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L. Westlake et al.
RHEUMATOLOGY (2010)
Atheroprotective Effects of Methotrexate on Reverse Cholesterol Transport Proteins and Foam Cell Transformation in Human THP-1 Monocyte/Macrophages
Allison B. Reiss et al.
ARTHRITIS AND RHEUMATISM (2008)
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients
Hilal Maradit Kremers et al.
ARTHRITIS AND RHEUMATISM (2008)
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
Antonio Naranjo et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-α
Alexander Niessner et al.
CIRCULATION (2006)
Cardiovascular toxicities of immunosuppressive agents
LW Miller
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
Share Paper
